Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

DOI: 10.1177/2040622319843756

Keywords: biologic failure, real-world, reimbursement, secukinumab, tumor necrosis factor-α inhibitors, ustekinumab

Full-Text